His primary areas of study are COPD, Intensive care medicine, Physical therapy, Internal medicine and Asthma. He does research in COPD, focusing on Obstructive lung disease specifically. Nicolas Roche interconnects Executive summary and Severity of illness in the investigation of issues within Obstructive lung disease.
The Intensive care medicine study combines topics in areas such as Cohort study, Quality of life, Guideline, Disease and Respiratory system. His Physical therapy research is multidisciplinary, incorporating elements of Stroke, Observational study, Spirometry and Comorbidity. The Asthma study combines topics in areas such as Medical prescription and Pediatrics.
Nicolas Roche mainly investigates COPD, Internal medicine, Physical therapy, Intensive care medicine and Asthma. His COPD research incorporates themes from Pulmonary disease, Exacerbation, Mortality rate and Disease. His Internal medicine study frequently draws connections to other fields, such as Surgery.
His Physical therapy study integrates concerns from other disciplines, such as Spirometry and Physical medicine and rehabilitation. The study of Intensive care medicine is intertwined with the study of MEDLINE in a number of ways. His study in Asthma focuses on Inhaler and Asthma control.
Nicolas Roche focuses on COPD, Internal medicine, Intensive care medicine, Asthma and Pulmonary disease. His work in the fields of COPD, such as Indacaterol, overlaps with other areas such as In patient. His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
Intensive care medicine is often connected to MEDLINE in his work. His Asthma research incorporates elements of mHealth, Observational study and Physical therapy. Nicolas Roche studies Pulmonary disease, namely Obstructive lung disease.
His scientific interests lie mostly in COPD, Internal medicine, Asthma, Intensive care medicine and Randomized controlled trial. His COPD research is multidisciplinary, incorporating perspectives in Pulmonary disease, Inhaled corticosteroids, Bronchodilator, Cohort and Comorbidity. His research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Fluticasone propionate, Moderate to severe, Blood eosinophil, Adverse effect and Maintenance therapy.
His Asthma research focuses on mHealth and how it connects with Family medicine, Health literacy, Disease and Change management. Nicolas Roche interconnects Clinical trial, MEDLINE, Asthma copd overlap, Asthma chronic and Obstructive lung disease in the investigation of issues within Intensive care medicine. His studies examine the connections between Inhaler and genetics, as well as such issues in Budesonide/formoterol, with regards to Physical therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2017)
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Jadwiga A Wedzicha;Donald Banerji;Kenneth R Chapman;Jørgen Vestbo.
The New England Journal of Medicine (2016)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Jérôme Hadjadj;Nader Yatim;Laura Barnabei;Aurélien Corneau.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes.
European Respiratory Journal (2019)
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
V Giraud;N Roche.
European Respiratory Journal (2002)
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
Bartolome R. Celli;Marc Decramer;Jadwiga A. Wedzicha;Kevin C. Wilson.
American Journal of Respiratory and Critical Care Medicine (2015)
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
P.-R. Burgel;J.-L. Paillasseur;D. Caillaud;I. Tillie-Leblond.
European Respiratory Journal (2010)
Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
Pierre-Régis Burgel;Pascale Nesme-Meyer;Pascal Chanez;Denis Caillaud.
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
Matthieu Mahévas;Viet Thi Tran;Mathilde Roumier;Amélie Chabrol.
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Alberto Papi;Jørgen Vestbo;Leonardo Fabbri;Leonardo Fabbri;Massimo Corradi.
The Lancet (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: